drugset / Trial / NCT03020472
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age
Phase 4
Terminated
6 enrolled
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
NaSingle-groupOpen-labelBasic science
Summary
This pilot study will investigate B-cell responses following vaccination with live, attenuated influenza vaccine (LAIV) in healthy children 2 years of age from blood samples taken at designated time points before and after vaccination.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluMist | Vaccine | — | Intranasal |